Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services

New Zealand Medical Journal

Volumn 124, Issue 1339, 2011, Pages 51-58

  Oliphant, Jeannie ^a   Perkins, Nicky ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONDYLOMA ACUMINATUM; FEMALE; GROUPS BY AGE; HEALTH CARE COST; HEALTH SERVICE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; NONHUMAN; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; TREND STUDY; VACCINATION;

ADOLESCENT; ADULT; CHILD; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; INCIDENCE; MALE; NEW ZEALAND; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POISSON DISTRIBUTION; RETROSPECTIVE STUDIES;

EID: 79961040927     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Warner RH. Human papillomavirus infection: a concise review of natural history. Obstetrics & Gynecology. 2009;114(1):139-43.
2. Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6,11,16 and 18) vaccine. Journal of Infectious Diseases. 2009;199:805-14.
3. Jones RW, Coughlan EP, Reid JS, et al. Human papilloma virus vaccines and their role in cancer prevention. The New Zealand Medical Journal. 2007;120(1266):1-7.
4. Winer RL, Kiviat NB, Hughes JP, et al. Development and duration of human papillomavirus lesions, after initial infection. Journal of Infectious Diseases. 2005;191:731-8.
5. Guidelines for the Management of Genital Human Papillomavirus (HPV) in Australia and New Zealand. 5th Edition. 2007.
6. Lawrence S, Walzman M, Sheppard S, et al. The psychological impact caused by genital warts: has the Department of Health's choice of vaccination missed the opportunity to prevent such morbidity? International Journal of STD & AIDS. 2009;20:696-700.
7. Brotherton JML, Heywood A, Heley S. The incidence of genital warts in Australian women prior to the national vaccination program. Sexual Health. 2009;6:178-84.
8. Brotherton JML, Kaldor JM, Garland SM. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy. Sexual Health. 2010;7:310-9.
9. Fairley CK, Hocking JS, Gurrin LC, et al. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sexually Transmitted Infections. 2009;85:499-502.
10. Brotherton JML, Deeks SL, Campbell-Lloyd S, et al. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. CDI. 2008;32(4):457-61.
11. Grulich AE, Jin F, Conway EL, et al. Cancers attributable to human papillomavirus infection. Sexual Health. 2010;7:244-52.
12. Brotherton JML, Fairley CK, Garland SM et al. Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine. Sexual Health. 2010;7:397-98.